Parkinson’s Disease Shirley H. Wray, M.D., Ph.D., Professor of Neurology, Harvard Medical School Director, Unit for Neurovisual Disorders Massachusetts.

Slides:



Advertisements
Similar presentations
Why do we move our eyes? - Image stabilization
Advertisements

Saccades and Saccadic Oscillations
Parkinson’s Disease (PD)
Parkinson’s Disease Dr Rachel Cary, Warwick Hospital.
905-1 Horizontal Gaze Palsy. Left esotropia; fascicular sixth nerve palsy, left horizontal gaze palsy.
NANOS Skills Transfer Session Gaze Testing / Rucker and Thurtell (handout created by R. John Leigh, M.D.) Range of Movement and Ocular Alignment Establish.
BASAL NUCLEI (Basal Ganglia).
Basal Ganglia and Motor Control L21
Basal Ganglia, Cerebellum and Movement
THE BRAIN’S CONTROL OF HORIZONTAL SACCADIC EYE MOVEMENTS Shirley H. Wray, M.D., Ph.D.
Progressive Supranuclear Palsy Shirley H. Wray, M.D., Ph.D. Professor of Neurology, Harvard Medical School Director, Unit for Neurovisual Disorders Massachusetts.
Internuclear Ophthalmoplegia in Childhood Shirley H. Wray, M.D., Ph.D. Professor of Neurology, Harvard Medical School Director, Unit for Neurovisual Disorders.
Brain Control of Movement. Motor Control Hierarchy  High level – plans and executes strategy Association areas of cortex Basal ganglia gives the “go”
207-2 Selective Saccadic Palsy. Selective Saccadic Palsy after Cardiac Surgery Selective loss of all forms of saccades (voluntary and reflexive quick.
Alcoholic Cerebellar Degeneration Clinical Syndrome The clinical syndrome of alcoholic cerebellar degeneration is remarkably stereotyped. The usual.
PHL 437/Pharmacogenomics Fourth Lecture (Parkinson’s disease) By Abdelkader Ashour, Ph.D. Phone:
Parkinson’s Disease Pathology 430/826 The Molecular Basis of Disease Neurological Genetics 9 th March 2015 Dr. John Rossiter
Paul Short, Ph.D. The Parkinson’s Coach NEUROPSYCHOLOGY OF PARKINSON’S COMMUNICATION PROBLEMS.
Pendular Vertical Oscillations Shirley H. Wray, M.D., Ph.D. Professor of Neurology, Harvard Medical School Director, Unit for Neurovisual Disorders Massachusetts.
One and a Half Syndrome Shirley H. Wray, M.D., Ph.D. Professor of Neurology, Harvard Medical School Director, Unit for Neurovisual Disorders Massachusetts.
Frontotemporal Dementia Eye Movements This patient with frontotemporal dementia (FTD) has a complete paralysis of horizontal saccadic eye movements.
Dementia. Definition Loss of function in multiple cognitive abilities Assuming the individual had normal abilities before the onset Many of the 70 recognized.
Parkinson’s Disease and Treatment Shalla Hanson Medicinal Chemistry April 2009.
931-4 Convergence Insufficiency. History A 73-year old man with known PD for 10 years, complained of horizontal double vision for 18 months. He could.
Dr. Kleyn Department of Geriatric Medicine SVCMC
JP Parkinson’s Disease. Overview Idiopathic PD Clinically and pathologically distinct from other parkinsonian syndromes Degenerative disorder of the CNS.
Parkinson’s Disease By Devin Cornford
The oculomotor system Or Fear and Loathing at the Orbit Michael E. Goldberg, M.D.
Neurodegeneration is the umbrella term for the progressive loss of structure or function of neurons, including death of neurons. Many neurodegenerative.
Chiari-1 Malformation Shirley H. Wray, M.D., Ph.D. Professor of Neurology, Harvard Medical School Director, Unit for Neurovisual Disorders Massachusetts.
Parkinson’s Disease. Definition Parkinson's disease (PD) is an idiopathic, slowly progressive, neurodegenerative disorder whereby two or more of the following.
Parkinson’s Disease superKAT :).
Alzheimer’s Disease The most common cause of Dementia –Progressive Memory Loss Plus loss in one other area of cognition: Perception Attention Language/Symbols.
PARKINSON’S DISEASE By Courtney and Niral. WHAT IS IT?  Parkinson's disease (PD) is chronic and progressive movement disorder, meaning that symptoms.
PhD MD MBBS Faculty of Medicine Al Maarefa Colleges of Science & Technology Faculty of Medicine Al Maarefa Colleges of Science & Technology Lecture – 9:
MOTOR AREAS EXTRAPYRAMIDAL SYSTEM
BASAL GANGLIA Basal ganglia are subcorticle nuclei of grey matter located in the interior part of cerebrum near about base 3.
Ocular Motor Apraxia Revisited In honor of Carol Francis Zimmerman, M.D Shirley H. Wray, M.D., Ph.D. FRCP.
Familial Amyotrophic Lateral Sclerosis Pseudobulbar Palsy Dysarthria and dysphagia Diminished palatal movement with positive gag bilaterally Diminished.
 Parkinson’s Disease (PD) -progressive neurodegenerative disease affecting motor ability -third most common neurologic disorder of older adults.
By: Alejandro Navarro and Andrea Ors. Content Introduction What is Parkinson's disease? What causes the disease? History Main symptoms Treatment Statistics.
A 53-year-old male with clumsiness Leonidas Arvanitis, M.D. Neuropathology Fellow, PGY-6.
Figure 18.1 Motor components of the human basal ganglia.
second most common neurodegenerative disorder progressive loss of muscle control trembling of the limbs and head while at rest stiffness, slowness, and.
By Katelyn Chaimson and Sean Guyot
Α-synuclein transgenic mouse models of Parkinson’s disease Michelle Maurer December 2015.
Extrapyramidal pathway
PARKINSON’S DISEASE Jeanette J. Norden, Ph.D. Professor Emerita Vanderbilt University School of Medicine.
Parkinson’s Test Device Development Tiffany Feltman Erin Sikkel.
Pathogenesis and pathology of parkinsonism
STRUCTURE AND CIRCUITS OF THE BASAL GANGLIA Rastislav Druga Inst. of Anatomy, 2nd Medical Faculty.
Emma Hahs, Brooke Armistead, Sarah Brown, Sok Kean Khoo Department of Cell and Molecular Biology, College of Liberal Arts and Sciences, Grand Valley State.
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Pharmacological Treatment of Parkinson Disease: A.
Parkinson's disease ♦ Is a neurodegenerative disorder ♦ Develops around age 50 * incidence rises with age * affects 1-2% of population > age 65 ♦ Higher.
PARKINSON’S DISEASE CHAMINDA UNANTENNE RN,MS,MSN.
Direct motor pathway Corticospinal pathway. Motor Units – Large Versus Small Text Fig
“HEALTH IS THE BEST” In the name of God. WHAT IS IT? Parkinson's disease (PD) is a chronic and progressive movement disorder, meaning that symptoms.
Direct motor pathway Corticospinal pathway.
Parkinson’s disease by Syed Baseeruddin Alvi (09).
Parkinson’s Disease.
Dementia with Lewy Bodies
The ageing brain Volume reduction: begins around 50 with a loss of brain weight of around 2-3% per decade Changes in nerve cell numbers and size - various.
Parkinson's disease KRZYSZTOF NICPOŃ.
Chapter 10 The Ocular Motor System: Gaze Disorders.
“The effects of chronic changes to the functioning of the nervous system due to interference to neurotransmitter function, illustrated by the role of Dopamine.
III. Parkinson Disease.
Atypical Parkinsonian Syndromes
Basal ganglia function
Neurodegenerative diseases
Basal ganglia: New therapeutic approaches to Parkinson's disease
Presentation transcript:

Parkinson’s Disease Shirley H. Wray, M.D., Ph.D., Professor of Neurology, Harvard Medical School Director, Unit for Neurovisual Disorders Massachusetts General Hospital

Presenting Symptoms Shuffling gait Marked bradykinesia Increasing rigidity Diplopia reading

Ocular Motor Performance Observe head position and posture Head movement + gaze Random eye movements Head tremor Eyelids blink rate (normal 25-30/min) Blepharospasm, clonus or apraxia Glabella hyperreflexia

Ocular Motor Signs Impaired convergence Slow hypometric horizontal saccades Normal vertical saccades Saccadic substitution for smooth horizontal pursuit

Convergence Insufficiency Three factors: Age Parkinson’s disease Medication (Sinemet)

Ocular Motor Deficits in PD The dopaminergic nigrostriatal pathways affected in PD control the latency, velocity and amplitude of saccades and the gain (ratio of smooth EM velocity to target velocity) of smooth pursuit. Dysfunction of striatonigral-collicular circuits lead to abnormalities of normal programming of eye-head saccades.

Saccadic EM in PD Reflexive saccades to stimuli normal Volitional saccades impaired Abnormal initiation and slow velocity Refixaiton saccades Decreased amplitude, Hypometria, Increased saccadic latencies, Akinesia Hypometria + Akinesia causes bradykinesia Anti-saccades normal

Potential nigro-colliculo-reticular sites which may disrupt saccades Frontal eye field (FEF) + sup. colliculus (SC) lesion leads to slowed small saccades FEFs project to corpus striatum, which has major outflow via substantia nigra pars reticulata (SNPR) to SC Cells in SNPR which modulate with saccades and project through SC may be dysfunctional SC activates pause cells in pontine RF

PD: Eye Movements Pursuit EM Slow and fast tracking Acceleration/de-acceleration Convergence Reflex EM Doll’s head and Bell’s Test for a phoria as cause of diplopia Alternate eye cover, distance and near

The severity of ocular motor impairment in PD correlates with the duration of the disease and the severity of bradykinesia and rigidity.

Courtesy of Mendez F. Cummengo JL. Dementia: A Clinical Approach. Third Edition. Butterworth Heinmann 2003.

The following illustrations of The brain MRI Pathology of the midbrain Lewy body are taken from the case of an elderly woman with Parkinson’s Disease

Figure 1 Normal axial T2W1 through the midbrain shows the hypointense red nuclei and substantia nigra are separated by the pars compacta.

Figure 2 In a patient with PD, the Axial T2W1 shows midbrain volume loss, especially the pars compacta, as shown by “touching” red nuclei and substantia nigra Courtesy Anne Osborn, MD

Figure 3 An autopsy in a patient with PD shows volume loss in the midbrain with pale-staining substantia nigra and decreased size of the pars compacta.

Figure 4 Section of the brain showing cytoplasmic inclusion body within a surviving neuron with an eosinophilic core surrounded by a clear halo. The Lewy body is not entirely specific, but it is a highly sensitive marker for PD.

Parkinson’s Disease Due to dopaminergic cell death leading to dopamine deficiency Defective gene for  synuclein on Chr. 4q Second locus on Chr. 2p

References Mendez MF and Cummings JL. Parkinsonian Disorders with Dementia. Ch. 7 Pg Dementia a Clinical Approach, Third Edition, Butterworth-Heine, 2003.